Explore our scientific resources

Get our newsletters

Published on the 19 May 2025

POSTER: “NEUROINFLAMMATION MODELS OF NEURODEGENERATIVE DISEASES”

Dr Ahmad Allouche, Head of in vitro biology, presented the team’s research* during at Venusberg Neuroinflammation Meeting 2025 in Luxembourg in his poster “NEUROINFLAMMATION MODELS OF NEURODEGENERATIV…

Posters
Published on the 4 April 2025

POSTER: “ADVANCING ALZHEIMER’S DISEASE MODELS FOR PRECLINICAL DRUG TESTING”

Dr Ahmad Allouche, Head of in vitro biology, presented the team's research* during AD/PD 2025 in Vienna in his poster "ADVANCING ALZHEIMER'S DISEASE MODELS FOR PRECLINICAL DRUG TESTING". Learn more…

Posters
Published on the 12 March 2025

Technical Note: High-content imaging of brain-on-chip microfluidic devices using PreciScan intelligent acquisition.

Brain-on-chips (BoC) are innovative tools that simulate complex brain environments, enhancing our understanding of neurodegenerative diseases (NDDs). While a range of BoC platforms have been developed…

Technical notes
Published on the 11 March 2025

Publication: “Urolithin A provides cardioprotection and mitochondrial quality enhancement preclinically and improves human cardiovascular health biomarkers”

Cardiovascular diseases (CVDs) are the leading cause of global mortality. That's why we are proud to share a groundbreaking study titled "Urolithin A provides cardioprotection and mitochondrial qualit…

Publications
Published on the 12 February 2025

A signifiant milestone for our publication on Nutrients journal

We wanted to highlight on our recent article on our psychopharmacology research "The Anxiolytic-like Properties of a Tryptic Hydrolysate of Bovine αs1 Casein Containing α-Casozepine Rely on GABAA Rece…

Publications
Published on the 8 February 2025

POSTER: “Translational Relevance and Versatility of the Thromboembolic Stroke Model in Mice: Implications for Pharmacological and Safety Evaluations”

Dr Annelise LETOURNEUR, Director of Operations at STROK@LLIANCE and Neuroscience Study Director, presented the team's research* during the American Heart Association’s annual International Stroke Conf…

Posters
Published on the 31 July 2024

POSTER: “Effect of SGLT2i on RV failure: comparison between Empagliflozin and current therapies in a preclinical model of RV dysfunction PAH-induced”

Presented by Christophe Muller at the Heart Failure Drug Discovery & Development Summit (in July-August 2024, in Boston, USA, MA). EASY POSTER REQUEST Authors: Guillaume Bourdier1, Jess…

Posters
Published on the 8 January 2024

Improving Stroke Outcomes in Hyperglycemic Mice by Modulating tPA/NMDAR Signaling to Reduce Inflammation and Hemorrhages

The pharmacological intervention for ischemic stroke hinges on intravenous administration of the recombinant tissue-type plasminogen activator (rtPA, Alteplase/Actilyse®) either as a standalone treatm…

Publications